MetLife Investment Management, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q1 2020$1,063,006
-36.3%
78,8580.0%0.02%
-11.8%
Q4 2019$1,668,635
+59.6%
78,8580.0%0.02%
+41.7%
Q3 2019$1,045,657
-4.4%
78,8580.0%0.01%0.0%
Q2 2019$1,093,758
-12.5%
78,858
+21.2%
0.01%
-14.3%
Q1 2019$1,249,611
+34.6%
65,0500.0%0.01%
+16.7%
Q4 2018$928,264
-40.8%
65,050
-13.6%
0.01%
-29.4%
Q3 2018$1,568,749
+9.7%
75,312
+24.7%
0.02%0.0%
Q2 2018$1,430,000
+96.4%
60,415
+21.3%
0.02%
+88.9%
Q1 2018$728,000
-9.6%
49,8030.0%0.01%0.0%
Q4 2017$805,00049,8030.01%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 17,714,461$368,992,00016.94%
ACUTA CAPITAL PARTNERS, LLC 2,055,500$42,816,00015.27%
Foresite Capital Management III, LLC 2,691,729$56,069,00012.37%
Foresite Capital Management IV, LLC 1,231,543$25,653,0008.41%
NEXTHERA CAPITAL LP 1,398,577$29,132,0005.58%
Palo Alto Investors LP 5,013,764$104,437,0004.22%
Ghost Tree Capital, LLC 883,823$18,410,0003.91%
First Light Asset Management, LLC 1,151,622$23,988,0003.87%
DLD Asset Management, LP 3,403,000$70,918,0003.51%
RA Capital Management 3,119,778$64,985,0003.47%
View complete list of IMMUNOMEDICS INC shareholders